Post-COVID Neuropsychiatric Complications in Children and Adolescents: a Study Design for Early Diagnosis and

Dania Gadelshina1, Timur Syunyakov, Arseny J Gayduk

  • 1Samara State Medical University, Samara, Russia.

Psychiatria Danubina
|October 6, 2023
PubMed

Insights

This study investigates COVID-19's impact on children's neuropsychiatric health, developing predictive models for complications and long COVID symptoms. Findings aim to improve prevention and personalized care strategies for pediatric patients.

Area of Science:

  • Pediatric neuropsychiatry
  • Infectious disease epidemiology
  • Machine learning in healthcare

Background:

  • The COVID-19 pandemic poses long-term risks to children's physical health, socio-psychological well-being, and cognitive development.
  • Further investigation is needed to understand and address these neuropsychiatric complications.
  • This study protocol aims to identify and manage these issues in pediatric populations.

Purpose of the Study:

  • To design a study protocol for recognizing neuropsychiatric complications in children and adolescents post-COVID-19.
  • To develop evidence-based prevention and treatment strategies.
  • To create mobile applications for diagnosing and treating affective, cognitive, and behavioral conditions.

Main Methods:

  • Two cohorts of 163 participants (ages 7-18) each: one with a history of COVID-19, one without.
  • Comprehensive assessments including neuropsychiatric evaluations, blood tests, and validated questionnaires.
  • Machine learning techniques for predictive modeling of COVID-19-associated neuropsychiatric complications.

Main Results:

  • Development of a binary classification model to distinguish between participants with and without COVID-19 history.
  • Clustering of significant indicators for the persistence of somatic and neuropsychiatric symptoms.
  • Predictive modeling for personalized trajectories of affective, behavioral, cognitive, and somatic symptoms in long COVID.

Conclusions:

  • The study protocol enhances understanding of COVID-19 neuropsychiatric effects in children and adolescents.
  • Aims to develop mobile applications for diagnosing and treating affective, cognitive, and behavioral conditions.
  • Informs improved preventive and personalized care strategies for pediatric COVID-19 patients.
Abstract